Gerresheimer interim CEO Röhrhoff steps down
Analysis based on 7 articles · First reported Aug 24, 2026 · Last updated Aug 24, 2026
The leadership change is a minor corporate event with limited direct market impact. Investors may view the transition as orderly given the clear succession plan and the company's ongoing strategic divestitures, but uncertainty about interim leadership could slightly weigh on sentiment.
On August 24, 2026, Uwe Röhrhoff stepped down as interim CEO of Gerresheimer at his own request, a few weeks before his term was set to end in October 2026. He had been appointed in November 2025 during a challenging period. The Supervisory Board, chaired by Axel Herberg, respected his decision and thanked him for his dedication. Until further notice, CFO Wolf Lehmann and Management Board member Achim Schalk will assume his duties. During his tenure, Röhrhoff helped stabilize the company and address key issues, including the agreement signed in late July 2026 to sell the U.S. subsidiary Centor and the global Primary Packaging Plastics business, which is expected to optimize capital structure and reduce leverage. Gerresheimer is a global provider of primary packaging and drug delivery systems for pharma, biotech, and cosmetic industries, with 39 production sites and revenues of around EUR 2.3bn in 2025 together with Bormioli Pharma.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard